KeyBank National Association’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-25,172
Closed -$194K 1226
2025
Q3
$194K Buy
25,172
+2,296
+10% +$16.1K ﹤0.01% 1146
2025
Q2
$167K Sell
22,876
-126
-0.5% -$1.02K ﹤0.01% 1140
2025
Q1
$218K Sell
23,002
-90
-0.4% -$1.12K ﹤0.01% 1074
2024
Q4
$381K Buy
23,092
+4,197
+22% +$65.2K ﹤0.01% 909
2024
Q3
$279K Buy
18,895
+1,451
+8% +$22.7K ﹤0.01% 1003
2024
Q2
$242K Buy
17,444
+2,464
+16% +$34.9K ﹤0.01% 999
2024
Q1
$235K Buy
+14,980
New +$231K ﹤0.01% 1001
2021
Q4
Sell
-5,199
Closed -$251K 1088
2021
Q3
$251K Sell
5,199
-23
-0.4% -$1.06K ﹤0.01% 988
2021
Q2
$236K Sell
5,222
-4,233
-45% -$188K ﹤0.01% 1004
2021
Q1
$456K Sell
9,455
-674
-7% -$35.1K ﹤0.01% 817
2020
Q4
$545K Sell
10,129
-253
-2% -$11.4K ﹤0.01% 739
2020
Q3
$383K Buy
10,382
+302
+3% +$11.2K ﹤0.01% 768
2020
Q2
$312K Buy
10,080
+134
+1% +$3.71K ﹤0.01% 800
2020
Q1
$275K Buy
9,946
+431
+5% +$12.9K ﹤0.01% 785
2019
Q4
$278K Buy
+9,515
New +$227K ﹤0.01% 884
2019
Q3
Sell
-9,918
Closed -$218K 1009
2019
Q2
$218K Buy
+9,918
New +$218K ﹤0.01% 937

Other funds holding NEO

KeyBank National Association's NEO Position: Q4 2025 in Review

KeyBank National Association sold out of NeoGenomics (NEO) in Q4 2025, closing a stake of 25,172 shares — an estimated $194K sold.

KeyBank National Association first reported a position in NEO in Q2 2019 and held it in 16 quarters. The position peaked at $545K in Q4 2020. 256 funds tracked by Wall St. Rank hold NEO as of Q4 2025.

  • KeyBank National Association reported no remaining NeoGenomics position as of Q4 2025 after selling out during the quarter.
  • KeyBank National Association sold 25,172 NeoGenomics shares in Q4 2025, an estimated $194K.
  • KeyBank National Association first reported a position in NeoGenomics in Q2 2019 and held it in 16 quarters.
  • KeyBank National Association's NeoGenomics position peaked at $545K in Q4 2020.
  • 256 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2025.

Based on KeyBank National Association's 13F filing for Q4 2025, filed 30 Jan 2026.